These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20298568)

  • 1. Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus.
    Levy J; Cobas RA; Gomes MB
    Diabetol Metab Syndr; 2010 Mar; 2():16. PubMed ID: 20298568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
    Blonde L; Dailey GE; Jabbour SA; Reasner CA; Mills DJ
    Curr Med Res Opin; 2004 Apr; 20(4):565-72. PubMed ID: 15119994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state pharmacokinetics of a novel extended-release metformin formulation.
    Timmins P; Donahue S; Meeker J; Marathe P
    Clin Pharmacokinet; 2005; 44(7):721-9. PubMed ID: 15966755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fed and Fasted Single-dose Assessment of Bioequivalence of Dapagliflozin and Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
    Boulton DW; Chang M; Griffen SC; Kitaura C; Lubin S; Pollack A; LaCreta F
    Clin Ther; 2016 Jan; 38(1):99-109. PubMed ID: 26682500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of once- or twice-daily extended release metformin compared with thrice-daily immediate release metformin in type 2 diabetes mellitus.
    Bhansali A; Masoodi SR
    J Assoc Physicians India; 2005 May; 53():441-5. PubMed ID: 16124352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin extended release: metformin gastric retention, metformin GR, metformin XR.
    Drugs R D; 2005; 6(5):316-9. PubMed ID: 16128603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose Comparison And Side Effect Profile Of Metformin Extended Release Versus Metformin Immediate Release.
    Hameed M; Khan K; Salman S; Mehmood N
    J Ayub Med Coll Abbottabad; 2017; 29(2):225-229. PubMed ID: 28718236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence, Food Effect, and Steady-State Assessment of Dapagliflozin/Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
    Chang M; Liu X; Cui D; Liang D; LaCreta F; Griffen SC; Lubin S; Quamina-Edghill D; Boulton DW
    Clin Ther; 2015 Jul; 37(7):1517-28. PubMed ID: 26048185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages of extended-release metformin in patients with type 2 diabetes mellitus.
    Jabbour S; Ziring B
    Postgrad Med; 2011 Jan; 123(1):15-23. PubMed ID: 21293080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures.
    Neutel JM; Zhao C; Karyekar CS
    Diabetes Ther; 2013 Dec; 4(2):269-83. PubMed ID: 23881432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review.
    Tan J; Wang Y; Liu S; Shi Q; Zhou X; Zhou Y; Yang X; Chen P; Li S
    Front Pharmacol; 2021; 12():669814. PubMed ID: 34079464
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult subjects.
    Boulton DW; Smith CH; Li L; Huang J; Tang A; LaCreta FP
    Clin Drug Investig; 2011; 31(9):619-30. PubMed ID: 21819160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-dose combination therapy in type 2 diabetes mellitus.
    Blonde L; San Juan ZT; Bolton P
    Endocr Pract; 2014 Dec; 20(12):1322-32. PubMed ID: 25370323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey.
    Liu C; Tang S; An K; Zhang S; Zhou Y; Su N; Yang R; Liao X; An Z; Li S
    Front Pharmacol; 2021; 12():634561. PubMed ID: 34322016
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiologic Surveillance of Glycemic Response to a Scored, Breakable, Extended Release, Fixed Dose Combination of Gliclazide and Metformin in Persons with Type 2 Diabetes.
    Kalra S; Das AK
    J Assoc Physicians India; 2017 Jun; 65(6):38-41. PubMed ID: 28782312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult Chinese subjects.
    Gummesson A; Li H; Gillen M; Xu J; Niazi M; Hirshberg B
    Clin Drug Investig; 2014 Nov; 34(11):763-72. PubMed ID: 25269885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of metformin: special focus on metformin extended release.
    Ali S; Fonseca V
    Expert Opin Pharmacother; 2012 Aug; 13(12):1797-805. PubMed ID: 22775758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence of Dapagliflozin/Metformin Extended-release Fixed-combination Drug Product and Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Russian Subjects.
    Khomitskaya Y; Tikhonova N; Gudkov K; Erofeeva S; Holmes V; Dayton B; Davies N; Boulton DW; Tang W
    Clin Ther; 2018 Apr; 40(4):550-561.e3. PubMed ID: 29548719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
    Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
    Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.